Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Galvus (Vildagliptin) Efficacy Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled by Metformin and Basal Insulin, This One Having Been Properly Titrated.

NCT01757587 is registered in ClinicalTrials.gov with Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète as lead sponsor.

NCT NCT01757587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01757587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Galvus (Vildagliptin) Efficacy Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled by Metformin and Basal Insulin, This One Having Been Properly Titrated.
Lead sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
March 31, 2015
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes